These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3236630)

  • 1. [Pharmacotherapy of cardiogenic shock and acute circulatory insufficiency based on bedside hemodynamic monitoring].
    Czarnecki W
    Kardiol Pol; 1988; 31(7):439-48. PubMed ID: 3236630
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic principles of the therapy of cardiogenic shock and acute circulatory failure].
    Czarnecki W
    Kardiol Pol; 1988; 31(7):428-38. PubMed ID: 2467035
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiac insufficiency and shock caused by acute myocardial infarction. Manipulation of hemodynamic parameters].
    Campagna C; Franco L; Perniola V
    Minerva Anestesiol; 1983 Nov; 49(11):653-8. PubMed ID: 6669276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Emergencies in dilated cardiomyopathy and myocarditis].
    Paleev NP; Mravian SP; Gurevich MA; Odinokova VA
    Kardiologiia; 1992; 32(11-12):107-10. PubMed ID: 1297869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of hemodynamic monitoring in acute myocardial infarct].
    De Marchi M; De Bernardi A; Sclavo MG; Bevilacqua R; Piccinino C; Minelli M; Bottone W; Angelino PF
    Minerva Cardioangiol; 1981 Apr; 29(4):115-22. PubMed ID: 7242942
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide.
    Mullie A; Lust P; Nievel J; Penninckx J; Vanhove L; Van Hoonacker G; Vendevelde K; Fenwick J; Coghill J
    Acta Anaesthesiol Belg; 1980; 31 Suppl():147-54. PubMed ID: 7457056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hemodynamics to differentiate pathophysiologic causes of cardiogenic shock.
    Daily EK
    Crit Care Nurs Clin North Am; 1989 Sep; 1(3):589-602. PubMed ID: 2684244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiogenic shock in acute myocardial infarction].
    Martínez A; Corbalán R; González R; Asenjo R; Illanes G; Rodríguez JA
    Rev Med Chil; 1986 Oct; 114(10):947-53. PubMed ID: 2883711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiogenic shock. Therapeutic principles].
    Reikvam A; Haerem J; Sivertssen E; Skjaeggestad O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(7):416-8. PubMed ID: 7157300
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiogenic shock].
    Trenckmann H
    Z Gesamte Inn Med; 1971 Jul; 26(13):Suppl:165-70. PubMed ID: 5125155
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of nonseptic cardiogenic circulatory failure].
    Griebenow R
    Klin Anasthesiol Intensivther; 1995; 47():122-8. PubMed ID: 7715169
    [No Abstract]   [Full Text] [Related]  

  • 15. [High-dose nitroglycerin in cardiogenic shock].
    Guglina ME
    Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shock caused by myocardial infarction--various problems of etiopathogenesis and treatment].
    Kuch J
    Kardiol Pol; 1985; 28(2):157-64. PubMed ID: 3900516
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
    Simoons ML; Muskens G; Hugenholtz PG
    Herz; 1983 Feb; 8(1):34-40. PubMed ID: 6832691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effect of dobutamine in cardiogenic shock].
    Coma Canella I; López-Sendón J
    Rev Esp Cardiol; 1981; 34(6):483-9. PubMed ID: 7339730
    [No Abstract]   [Full Text] [Related]  

  • 19. Bedside hemodynamic monitoring in the cardiac care unit.
    Chatterjee K
    Cardiovasc Clin; 1985; 15(1):253-68. PubMed ID: 3842330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.